- Home
- VBIX vs NRXP Comparison
VBIX vs NRXP Comparison
Compare VBIX & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VBIX
- NRXP
- Stock Information
- Founded
- VBIX N/A
- NRXP 2015
- Country
- VBIX Israel
- NRXP United States
- Employees
- VBIX N/A
- NRXP N/A
- Industry
- VBIX Computer Software: Prepackaged Software
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- VBIX Technology
- NRXP Health Care
- Exchange
- VBIX Nasdaq
- NRXP Nasdaq
- Market Cap
- VBIX 26.4M
- NRXP 32.6M
- IPO Year
- VBIX N/A
- NRXP N/A
- Fundamental
- Price
- VBIX $4.91
- NRXP $3.24
- Analyst Decision
- VBIX
- NRXP Strong Buy
- Analyst Count
- VBIX 0
- NRXP 4
- Target Price
- VBIX N/A
- NRXP $28.50
- AVG Volume (30 Days)
- VBIX 127.3K
- NRXP 212.8K
- Earning Date
- VBIX 08-14-2025
- NRXP 08-13-2025
- Dividend Yield
- VBIX N/A
- NRXP N/A
- EPS Growth
- VBIX N/A
- NRXP N/A
- EPS
- VBIX N/A
- NRXP N/A
- Revenue
- VBIX $19,672,000.00
- NRXP N/A
- Revenue This Year
- VBIX N/A
- NRXP N/A
- Revenue Next Year
- VBIX N/A
- NRXP N/A
- P/E Ratio
- VBIX N/A
- NRXP N/A
- Revenue Growth
- VBIX N/A
- NRXP N/A
- 52 Week Low
- VBIX $0.18
- NRXP $1.10
- 52 Week High
- VBIX $12.00
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- VBIX N/A
- NRXP 53.62
- Support Level
- VBIX N/A
- NRXP $2.90
- Resistance Level
- VBIX N/A
- NRXP $3.53
- Average True Range (ATR)
- VBIX 0.00
- NRXP 0.20
- MACD
- VBIX 0.00
- NRXP -0.04
- Stochastic Oscillator
- VBIX 0.00
- NRXP 58.73
About VBIX Viewbix Inc. Common Stock
ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.